Vijaypd Ceutical Limited (NSE: VIJAYPD) is a Mumbai, Maharashtra-based company in the Pharmaceutical Product Distribution industry. With a market capitalisation of ₹136 Cr, it ranks #2,982 by market cap among the 6,197 Indian listed companies on FinBizNet, and #8 of 13 in Pharmaceutical Product Distribution. The share price was ₹69.00 as of 16 Nov 2026.
| Current Price | ₹69.00 |
|---|---|
| Market Cap | ₹136 Cr |
| NSE Symbol | VIJAYPD |
| Sector | Health Care > Health Care Equipment and Services > Health Care Providers and Services |
| Sub-Industry | Health Care Distributors > Pharmaceutical Product Distribution |
| P/E Ratio | 23 |
| Return on Equity | 9.53% |
| Return on Assets | 3.20% |
| Beta (1Y) | -0.04 |
| Headquarters | Mumbai, Maharashtra |
| Website | www.vijaypdceutical.com |
Promoters held 56.43% of Vijaypd Ceutical Limited's shares as of Mar 2026, against 78.30% in Sept 2025 (−21.87 percentage points).
VijayPD Ceutical Limited distributes and supplies pharmaceutical products and consumer goods in India. It offers pharmaceutical and wellness products, such as medicines that include injections, tablets, capsules, ointments, suppositories, ophthalmic preparations, and liquid oral products; vitamins, hormones, enzymes, and wellness tonics; and serums and diagnostic test kits, as well as fast-moving consumer goods comprising personal care and toiletries, such as soaps, sanitizers, and baby care items; ayurvedic product; cosmetics and food products; and dental products and crude drugs. The company serves pharmacies, nursing homes, healthcare clinics, and wellness and consumer goods sectors. The company was incorporated in 1971 and is based in Mumbai, India.
1. Trading of pharmaceuticals-This segment distributes and supplies pharmaceutical products and consumer goods. 2. NA-NA 3. NA-NA 4. NA-NA
1. Trading of pharmaceuticals-100%
| Company | Market Cap | P/E | ROE | Latest Qtr Revenue | 1Y Change |
|---|---|---|---|---|---|
| Entero Healthcare Solutions Limited | ₹8,733 Cr | 74.6 | 8.28% | ₹2,087 Cr | +80.7% |
| Remus Pharmaceuticals Limited | ₹941 Cr | 26.1 | 13.78% | — | +0.6% |
| Health X Platform Limited (Sastasundar Ventures Ltd) | ₹871 Cr | 752.7 | -0.18% | ₹484 Cr | -5.7% |
| Aptus Pharma Limited | ₹837 Cr | 156.8 | — | — | +754.0% |
| Vasa Denticity Limited | ₹797 Cr | 76.5 | 6.68% | ₹87 Cr | -21.4% |
| Bijoy Hans Ltd | ₹523 Cr | — | — | — | +128.4% |
| Speciality Medicines Limited | ₹149 Cr | 11.5 | — | — | — |
| Vijaypd Ceutical Limited | ₹136 Cr | 23 | 9.53% | — | — |
| Royal Sense Limited | ₹39 Cr | 5.6 | — | — | -71.2% |
Listed by market capitalisation. Ratios are shown for context only.
Vijaypd Ceutical Limited is trading at ₹69.00, with a market capitalisation of ₹136 Cr.
Vijaypd Ceutical Limited operates in the Health Care > Health Care Equipment and Services > Health Care Providers and Services space (Health Care Distributors > Pharmaceutical Product Distribution).
Vijaypd Ceutical Limited has a P/E of 23 and a return on equity of 9.53%.
Vijaypd Ceutical Limited is listed on the NSE under the symbol VIJAYPD.
Promoters held 56.43% of Vijaypd Ceutical Limited's shares as of Mar 2026, against 78.30% in Sept 2025 (−21.87 percentage points).
Data as of 16 Nov 2026. Descriptive market data only — not investment advice.